Abstract: Despite the depth and breadth of Alzheimer’s Disease research, effective methods for treatment remain elusive. Technology is changing what we can do and how we can do it. Digital technologies have translated into a plethora of wearable sensors and smart home devices flooding the market, with more devices in the pipeline. They offer a solution for monitoring and detecting modifiable brain health related risk factors and behavioral symptoms well before changes meet the threshold for clinical diagnosis. The more transformative opportunity, however, lies in a shift from a medical intervention model of “personalized medicine” to a more comprehensive focus on “personalized brain health” that focuses on preventing disease altogether. Current and emerging artificial intelligence/data science approaches are critical to meeting this scientific vision but are highly dependent on access to high quality healthcare data resources. We address the challenge of shifting longstanding clinical research policies and practices to one centered on lowering the barriers to data sharing and embracing as well as incentivizing team science.
Bio: John A. Kelley, Jr., has been the Chairman and CEO of CereScan, a functional brain diagnostics company headquartered in Denver, Colorado since mid-2009. Previously, Mr. Kelley served as the Chairman, President, and Chief Executive Officer of McDATA Corporation, a provider of storage networking and data infrastructure solutions until Brocade Communications Systems, Inc. acquired McDATA in early 2007. Prior to joining McDATA, he served as Executive Vice President of Networks at Qwest Communications International from July 2000 to December 2000, after Qwest acquired US West in 2000. He was the President of Wholesale Markets for US West from May 1998 to July 2000. From 1995 to April of 1998, Mr. Kelley served as Senior Vice-President and General Manager of Large Business and Government Accounts as well as President of the Federal Systems Group. Before his employment at US West, he was the Area President for Mead Corporations Southwest Region from 1991 to 1994 and Vice President and General Manager of the Industrial Products Division for Mead in 1995. He has held senior leadership positions at NBI Corp., Alcatel/Friden, and Xerox Corporation. Mr. Kelley has been a member of the board of directors of Polycom, Inc. (NASDAQ) since March of 2000 and currently serves as the Chair of the Nominating and Governance Committee. He is also on the Board of Directors of Emulex Corporation (NYSE), and began that assignment in 2014. His private company board work has included Aztek Networks, Stored IQ, Circadence Corporation, and 3 Leaf Networks. Additionally, he has participated at the board level on several local and national non-profits. Mr. Kelley holds a BS in Business Management from the University of Missouri, St. Louis. He has served in the US Army (1970-1972) and also played varsity baseball at the University of Missouri, Columbia.
Chair & CEO, CereScan